NCT01100086View on ClinicalTrials.gov

A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2007

Study Completion Date

June 30, 2007

Conditions
Healthy Volunteers
Interventions
DRUG

Reformulated OXY (oxycodone HCl)

Reformulated OXY 10-mg tablet x 1 dose taken without food

DRUG

Original OxyContin® (OXY) (oxycodone HCl)

Original OxyContin® (OXY) 10-mg tablet x 1 dose taken without food

Trial Locations (1)

53704

Covance Clinical Research Unit Madison, Madison

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT01100086 - A Study to Determine the Fasting Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets | Biotech Hunter | Biotech Hunter